
Opinion|Videos|January 7, 2025
When to Consider Systemic Treatment for Prurigo Nodularis Patients
Author(s)TJ Chao, MPAS, PA-C
TJ Chao, MPAS, PA-C, discusses how systemic treatments for prurigo nodularis are considered for patients with moderate to severe disease, highlighting key patient-specific factors such as comorbidities and disease severity when initiating treatment.
Advertisement
Episodes in this series

Video content above is prompted by the following:
For which type of patient would you consider systemic treatments for prurigo nodularis patients?
What patient-specific factors do you consider when starting treatment?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Transformative Advances This Year and Beyond
5

















